Metformin use linked to reduced risk of myeloproliferative neoplasms

People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according to a study published in Blood Advances.

Related Keywords

Denmark ,Stidsholt ,Nordjylland ,United States ,Aalborg ,American ,Danish ,Daniel Tuyet Kristensen ,Aalborg University Hospital ,Aarhus University Hospital ,American Society Of Hematology ,Stidsholt Roug ,